An Entity of Type: Subsidiary, from Named Graph: http://dbpedia.org, within Data Space: dbpedia.org

Arena Pharmaceuticals, Inc. is an American biopharmaceutical company founded in 1997 and headquartered in San Diego, California. The company has small molecule drugs in development for possible clinical utility in multiple therapeutic areas. The company's most advanced investigational clinical programs are ralinepag (formerly APD811) in testing for pulmonary arterial hypertension (PAH), (formerly APD334) in evaluation for inflammatory indications and APD371 for the treatment of pain associated with Crohn's disease. In 2016, the company downsized and shifted its focus to developing new drugs currently being tested in clinical trials. In December 2021, Pfizer announced that it had agreed to acquire Arena for $6.7 billion in cash. In March 2022, it was announced the acquisition by Pfizer had

Property Value
dbo:abstract
  • Arena Pharmaceuticals, Inc. is an American biopharmaceutical company founded in 1997 and headquartered in San Diego, California. The company has small molecule drugs in development for possible clinical utility in multiple therapeutic areas. The company's most advanced investigational clinical programs are ralinepag (formerly APD811) in testing for pulmonary arterial hypertension (PAH), (formerly APD334) in evaluation for inflammatory indications and APD371 for the treatment of pain associated with Crohn's disease. In 2016, the company downsized and shifted its focus to developing new drugs currently being tested in clinical trials. In December 2021, Pfizer announced that it had agreed to acquire Arena for $6.7 billion in cash. In March 2022, it was announced the acquisition by Pfizer had been concluded. (en)
dbo:foundingYear
  • 1997-01-01 (xsd:gYear)
dbo:industry
dbo:thumbnail
dbo:type
dbo:wikiPageExternalLink
dbo:wikiPageID
  • 21470125 (xsd:integer)
dbo:wikiPageLength
  • 9434 (xsd:nonNegativeInteger)
dbo:wikiPageRevisionID
  • 1114710542 (xsd:integer)
dbo:wikiPageWikiLink
dbp:assets
  • (en)
  • 261M (en)
dbp:equity
  • (en)
  • 98.6M (en)
dbp:founded
  • 1997 (xsd:integer)
dbp:industry
dbp:keyPeople
  • Amit Munshi, CEO (en)
  • Dominic Behan, co-founder and senior scientist (en)
  • Jack Lief, co-founder (en)
  • Kevin Lind, CFO (en)
dbp:locationCity
dbp:locationCountry
  • U.S. (en)
dbp:logo
  • ArenaLogo.jpg (en)
dbp:name
  • Arena Pharmaceuticals (en)
dbp:netIncome
  • (en)
  • -85.5M (en)
dbp:operatingIncome
  • (en)
  • -57M (en)
dbp:products
  • Belviq (en)
dbp:revenue
  • (en)
  • 27.6M (en)
dbp:type
  • Subsidiary of Pfizer (en)
dbp:wikiPageUsesTemplate
dcterms:subject
rdf:type
rdfs:comment
  • Arena Pharmaceuticals, Inc. is an American biopharmaceutical company founded in 1997 and headquartered in San Diego, California. The company has small molecule drugs in development for possible clinical utility in multiple therapeutic areas. The company's most advanced investigational clinical programs are ralinepag (formerly APD811) in testing for pulmonary arterial hypertension (PAH), (formerly APD334) in evaluation for inflammatory indications and APD371 for the treatment of pain associated with Crohn's disease. In 2016, the company downsized and shifted its focus to developing new drugs currently being tested in clinical trials. In December 2021, Pfizer announced that it had agreed to acquire Arena for $6.7 billion in cash. In March 2022, it was announced the acquisition by Pfizer had (en)
rdfs:label
  • Arena Pharmaceuticals (en)
owl:sameAs
skos:closeMatch
prov:wasDerivedFrom
foaf:depiction
foaf:homepage
foaf:isPrimaryTopicOf
foaf:name
  • Arena Pharmaceuticals (en)
is dbo:wikiPageDisambiguates of
is dbo:wikiPageRedirects of
is dbo:wikiPageWikiLink of
is foaf:primaryTopic of
Powered by OpenLink Virtuoso    This material is Open Knowledge     W3C Semantic Web Technology     This material is Open Knowledge    Valid XHTML + RDFa
This content was extracted from Wikipedia and is licensed under the Creative Commons Attribution-ShareAlike 3.0 Unported License